Results 81 to 90 of about 70,358 (244)

Polyethylene glycol and prevalence of colorectal adenomas : Population-based study of 1165 patients undergoing colonoscopy [PDF]

, 2006
Background and aim — Dietary polyethylene glycol (PEG) is extraordinarily potent in the chemoprevention of experimental colon carcinogenesis. PEG is used to treat constipation in France and in the USA. French laxatives include Forlax® (PEG4000), Movicol®
Barbieux, Jean-Pierre, Bertrand, Philippe, Bougnoux, Philippe, Brondin, Brigitte, Corpet, Denis E., Dorval, Etienne, Jankowski, Jean Marie, Viguier, Jérôme   +7 more
core  

Seasonal malaria chemoprevention in Africa and China’s upgraded role as a contributor: a scoping review [PDF]

, 2023
Ming Xu, Yun-Xuan Hu, Shenning Lu, Muhammad Abdullahi Idris, Shuduo Zhou, Jian Yang, Xiang-Ning Feng, Yangmu Huang, Xian Xu, Ying Chen, Duoquan Wang   +10 more
openalex   +1 more source

Medicinal Plants and Lead Phytomolecules as Immunomodulators: An Updated Review

BioMed Research International, Volume 2026, Issue 1, 2026.
All therapeutic interventions aimed at modulating the immune response to pathogens, self‐antigens, carcinogens, or xenogeneic antigens are referred to as immunomodulation, which either prevents hyperactivation or restores the appropriate response of the immune system.
Gurdeep Singh, Vikas Sharma, Blessing Nnenna Udeh, Baisakhi Banerjee   +3 more
wiley   +1 more source

Cancer Chemoprevention Using Nanotechnology-Based Approaches

Frontiers in Pharmacology, 2020
Cancer research in pursuit of better diagnostic and treatment modalities has seen great advances in recent years. However, the incidence rate of cancer is still very high. Almost 40% of women and men are diagnosed with cancer during their lifetime.
Preshita Desai, Naga Jyothi Thumma, Pushkaraj Rajendra Wagh, Shuyu Zhan, Shuyu Zhan, David Ann, Jeffrey Wang, Sunil Prabhu   +7 more
doaj   +1 more source

Reference Profile Correlation Reveals Estrogen-like Trancriptional Activity of Curcumin [PDF]

, 2010
Background: Several secondary metabolites from herbal nutrient products act as weak estrogens (phytoestrogens), competing with endogenous estrogen for binding to the estrogen receptors and inhibiting steroid converting enzymes.
Albini, Adriana, Bachmeier, Beatrice E., Blengio, Fabiola, Dell'Eva, Raffaella, Esposito, Alessia, Generoso, Luca, Killian, Peter H., Mirisola, Valentina, Pfeffer, Ulrich, Romeo, Francesco   +9 more
core   +1 more source

Tyrer–Cuzick Lifetime Risk Is Not Associated With Non‐BRCA1/2 Pathogenic Variants for Breast Carcinoma

The Breast Journal, Volume 2026, Issue 1, 2026.
Background The Tyrer–Cuzick (TC) or IBIS risk calculator is a widely used tool to estimate the probability of developing breast cancer. The latest version incorporates various factors to assess the risk of breast cancer, including family history, personal history, breast density, and past medical history.
Divya Rao, Chloe Wernecke, Lisa Baron, Steven Cai, Peter Beitsch, Rakesh Patel, Pat Whitworth, Barry Rosen, Nhan Nguyen Tran, Kevin Hughes, Paul L. Baron, Imtiaz Wani   +11 more
wiley   +1 more source

The Combination of Sorafenib and PGV-1 Inhibits the Proliferation of Hepatocellular Carcinoma Through c-Myc Suppression in an Additive Manner: In Vitro Studies

Advances in Pharmacological and Pharmaceutical Sciences
Hepatocellular carcinoma (HCC) is one of the most aggressive types of liver cancer, and it is frequently associated with upregulated c-Myc expression.
Dhania Novitasari, Ikuko Nakamae, Noriko Yoneda-Kato, Jun-ya Kato, Yoshitaka Hippo, Yusuke Suenaga, Dyaningtyas Dewi Pamungkas Putri, Edy Meiyanto, Muthi’ Ikawati   +8 more
doaj   +1 more source

Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010 [PDF]

, 2012
PURPOSE: Two selective estrogen receptor modulators (SERMs), tamoxifen and raloxifene, have been shown in randomized clinical trials to reduce the risk of developing primary invasive breast cancer (IBC) in high-risk women. In 1998, the U.S. Food and Drug
A Cranney, A Fagerlin, AN Freedman, AN Freedman, Andrew N. Freedman, B Ettinger, B Fisher, C Holmberg, CP Kaplan, DA Paterniti, E Barrett-Connor, EA Waters, EA Waters, EA Waters, EA Waters, EL Korn, ER Port, Erika A. Waters, J Amsterlaw, J Cuzick, J Melnikow, JG Reeder, JH Dreyfuss, K Malek, K Visvanathan, LM Schwartz, ME Ropka, MH Gail, P Blaha, PE Goss, PM Ravdin, R Heisey, R Taylor, T Powles, Timothy S. McNeel, U Veronesi, VG Vogel, VG Vogel, Worta McCaskill Stevens   +38 more
core   +2 more sources

Supplementary Figure 1 from Prediction of Survival in Resected Non–Small Cell Lung Cancer Using a Protein Expression–Based Risk Model: Implications for Personalized Chemoprevention and Therapy [PDF]

, 2023
Kathryn A. Gold, Edward S. Kim, Diane D. Liu, Ping Yuan, Carmen Behrens, Luisa M. Solis, Humam Kadara, David C. Rice, Ignacio I. Wistuba, Stephen G. Swisher, Wayne L. Hofstetter, J. Jack Lee, Waun Ki Hong   +12 more
openalex   +1 more source

IMPROVMENT OF TUBERCULOSIS CHEMOPREVENTION IN HIV-INFECTED PATIENTS

Медицинский вестник Юга России, 2016
Objective: substantiation  for the use of various schemes for chemoprevention  of tuberculosis in HIV-infected patients.Materials and methods: for the study used data from the Cabinet of the early detection of tuberculosis outpatient card (form №025 ...
M. V. Sinitsyn, L. B. Ayusheva, L. V. Kolpakova   +2 more
doaj   +1 more source